Navigation Links
Neurobiological Technologies Reports Going Concern Qualification
Date:9/19/2007

EMERYVILLE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. announced today that its financial statements for the fiscal year ended June 30, 2007, included in the Company's Annual Report on Form 10-K filed on September 13, 2007, contain a going concern qualification from its independent accounting firm, Odenberg, Ullakko, Muranishi & Co. LLP.

As of June 30, 2007, the Company had cash and cash equivalents and short term investments of approximately $8.9 million. The Company recently filed a registration statement on Form S-1 to raise $65 million in an underwritten common stock offering, which is expected to close in October 2007.

This announcement is being made in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification. This announcement does not represent any change or amendment to the Company's 2007 financial statements or to its Annual Report on Form 10-K.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. ("NTI") is a specialty biopharmaceutical company with expertise in identifying and acquiring promising drug candidates and in designing and managing late-stage clinical trials for central nervous system conditions. NTI is currently developing Viprinex, a novel reperfusion agent that is in pivotal Phase 3 trials for the treatment of acute ischemic stroke.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the Company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement,
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Researchers Develop Technologies to Devour Food Pathogens
2. Researchers Study Safety of Assisted Reproductive Technologies
3. India to Propose Global Fund for Clean Energy Technologies
4. Autopsy reports could be valuable and informative
5. China reports declining number of SARS Cases
6. Russia Reports First SARS Case
7. Research reports that c-section deliveries are rising
8. Jharkhand reports 13,000 Malaria cases
9. Uganda Reports Failure To Contain Sleeping Sickness
10. WHO reports 36 million deaths world wide due to chronic diseases
11. Reports of Hantavirus infection in India raise concerns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... The age spots, wrinkles and puffy eyes ... of 30 are now explored in a new guide posted ... creams for women over 30 are introduced in the guide ... , The use of creams as an alternative to surgery ... cost, according to the information in the new guide. Because ...
(Date:7/23/2014)... Oklahoma (PRWEB) July 23, 2014 ... America’s leading provider of in-home care for seniors, ... Longevity Webinar Series featuring experts in a wide ... webinar will feature licensed clinical social worker and ... most common causes of caregiver stress and ways ...
(Date:7/23/2014)... YORK, NY, July 24, 2014) If past experience ... York State are about to get a lot more ... laws already on the books allowing NPs to provide ... to patient care and better relationships with physicians and ... a study from Columbia University School of Nursing, published ...
(Date:7/23/2014)... NJ (PRWEB) July 23, 2014 Celebrating ... for New Jersey today announced the awarding of $1,070,000 ... a special award in recognition of the Foundation’s 1,000th ... proud to continue our tradition of supporting community-based organizations ... the quality of life in the Garden State,” said ...
(Date:7/23/2014)... new study supports a growing body of research ... steroid hormones in treating postmenopausal breast cancer, with ... than with standard anti-hormone therapies. The study will ... open-access journal Reproductive Biology and Endocrinology . ... cancer in women in the United States. Approximately ...
Breaking Medicine News(10 mins):Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:New York law offers nurses more recognition, responsibility 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... 23 Medical images are increasingly becoming ... medical images poses an immense challenge in ... is essential that image archive storage solution ... vendors and image modality manufacturers become aware ...
... Tissue Sealants & Topical Hemostats Product Differentiation Innovation ... its revolutionary product - TachoSil. The innovative surgical ... of the European tissue sealants and topical hemostats ... TachoSil, is the sole company in the market ...
... care, serving local Colorado communities from six immediate care clinic locations ... ... Urgent care provider NextCare ( www.nextcare.com ) announces the opening of ... in Broomfield and Longmont now open and a location in Highlands ...
... principles similar to those that cause Jell-O to congeal ... are devising a new method of detecting nitric oxide ... nitric oxide in breath are a telltale sign of ... could prove useful in diagnosing illness and monitoring the ...
... patients are nervous, doctors say it isn,t as scary as ... part of Colorectal Cancer Awareness Month, Americans are being urged ... highly preventable type of cancer. , But many people are ... which is recommended if you,re age 50 or older or ...
... benefits and features on healthylivingnetwork.com. , ... Potomac, MD ... announce the latest benefits and features on healthylivingnetwork.com , a ... wide range of health concerns. Through its subsidiary Doctors, Preferred, Inc, ...
Cached Medicine News:Health News:Europe Poised for Exponential Growth in the Digitised Medical Imaging Storage Space, Reveals Frost & Sullivan 2Health News:Europe Poised for Exponential Growth in the Digitised Medical Imaging Storage Space, Reveals Frost & Sullivan 3Health News:Europe Poised for Exponential Growth in the Digitised Medical Imaging Storage Space, Reveals Frost & Sullivan 4Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 2Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 3Health News:Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation 4Health News:Three New NextCare Immediate Care Clinic Locations Open in Colorado 2Health News:U-M researcher's idea jells into potential new disease-detection method 2Health News:What to Expect From a Colonoscopy 2Health News:Healthylivingnetwork.com Announces Web Site Enhancements and Additional Product Offerings 2Health News:Healthylivingnetwork.com Announces Web Site Enhancements and Additional Product Offerings 3
(Date:7/23/2014)... 2014  The management team at Columbia Laboratories, ... a conference call on July 31, 2014, to ... June 30, 2014.  The call details are as ... am EDTDial-in numbers: , Toll free: (877) 870-4263 ... & archive): , www.columbialabs.com , under ,Investor, ...
(Date:7/23/2014)...  Silk Road Medical, Inc., a developer of ... and extra-cranial cerebrovascular disease, announced today the appointment ... position of Chief Technology Officer.  In this new ... Development efforts across its family of transcarotid access ... joining Silk Road Medical, Michael was the Vice ...
(Date:7/23/2014)... July 23, 2014  Dompe, a leader in R&D for ... that rhNGF (Recombinant Human Nerve Growth Factor) has been designated ... Administration (FDA). The candidate drug, developed by ... drug for the treatment of neurotrophic keratitis, a degenerative corneal ... and is currently without a cure. This is the ...
Breaking Medicine Technology:Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 2Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 3Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis 4
... N.C., July 27 Timothy Mastro,MD, FACP, DTM&H, ... 1st,as Senior Director of Research, will share information ... prevention at the,International AIDS Conference in Mexico City., ... Planned Trials," will examine ongoing and upcoming clinical ...
... BIRMINGHAM, Ala., July 28 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ... Phase II study of intravenous (i.v.) peramivir administered ... for the treatment of seasonal,influenza. The trial, conducted ... met its primary endpoint of improvement in the ...
Cached Medicine Technology:HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 4BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 5
... The only portable 36/70 static/kinetic/multi-color perimeter that ... room and costs only slightly more than ... perimeter,The Centerfield automatically performs static and kinetic ... to 70 with a fixation shift. Offers ...
... Wavefront Analyzer provides the practitioner with ... analysis system on the market today! ... auto refractometer, auto keratometer, and a ... benefits of wavefront measurement!, ,The KR-9000PW ...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
The new TOPCON 8800 Series of auto refractors and auto kerato-refractors satisfies the needs of today's demanding eyecare practice !...
Medicine Products: